ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis

BACKGROUND: The beta-2 adrenergic receptor (ADRB2) Arg16Gly polymorphism may alter the bronchodilation response to long-acting beta2-agonists, thereby influencing the clinical effectiveness of LABAs plus corticosteroids (ICS) treatment. But the results of individual studies are inconclusive. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xi, Li, Qian, Liu, Ruming, He, Jin, Wu, Di, Wang, Yun, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833872/
https://www.ncbi.nlm.nih.gov/pubmed/29670675
http://dx.doi.org/10.1155/2018/5712805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833872/
https://www.ncbi.nlm.nih.gov/pubmed/29670675
http://dx.doi.org/10.1155/2018/5712805

Ejemplares similares